J INTS BIO Reports Fourth-Generation EGFR Inhibitor JIN-A02 in Clinical Cancer ResearchNota de prensa12 febrero, 2026 · 08:13 | PR News
Fidelity Emerging Markets Equity Research Enhanced UCITS ETF - Net Asset Value(s)Nota de prensa12 febrero, 2026 · 08:03 | PR News
Fidelity EM Quality Income $ Acc FEMI - Net Asset Value(s)Nota de prensa12 febrero, 2026 · 08:03 | PR News
Fidelity ESG USD EM Bond UCITS ETF (GBP) - Net Asset Value(s)Nota de prensa12 febrero, 2026 · 08:03 | PR News
Fidelity EM Quality Income $ FEME - Net Asset Value(s)Nota de prensa12 febrero, 2026 · 08:03 | PR News
Fidelity ESG USD EM Bond UCITS ETF (USD) - Net Asset Value(s)Nota de prensa12 febrero, 2026 · 08:03 | PR News
Fidelity Europe Quality Income € FEUI - Net Asset Value(s)Nota de prensa12 febrero, 2026 · 08:03 | PR News
Fidelity Europe Quality Income € Acc FEQD - Net Asset Value(s)Nota de prensa12 febrero, 2026 · 08:03 | PR News